These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 20803495)

  • 21. Exploring the pharmacokinetics of oral ketamine in children undergoing burns procedures.
    Brunette KE; Anderson BJ; Thomas J; Wiesner L; Herd DW; Schulein S
    Paediatr Anaesth; 2011 Jun; 21(6):653-62. PubMed ID: 21355949
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of ketamine and its major metabolites norketamine, hydroxynorketamine, and dehydronorketamine: a model-based analysis.
    Kamp J; Jonkman K; van Velzen M; Aarts L; Niesters M; Dahan A; Olofsen E
    Br J Anaesth; 2020 Nov; 125(5):750-761. PubMed ID: 32838982
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rifampicin has a profound effect on the pharmacokinetics of oral S-ketamine and less on intravenous S-ketamine.
    Peltoniemi MA; Saari TI; Hagelberg NM; Laine K; Kurkinen KJ; Neuvonen PJ; Olkkola KT
    Basic Clin Pharmacol Toxicol; 2012 Nov; 111(5):325-32. PubMed ID: 22676424
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics of subcutaneous ketamine administration via the Omnipod® system in dogs.
    Colón C; Early P; Muñana K; Olby N; Mariani C; Mancini S; Fefer G; Li Z; Briley J; Bailey K; Lascelles D; Messenger K
    J Vet Pharmacol Ther; 2024 Jul; 47(4):353-358. PubMed ID: 38536664
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of S-ketamine during prolonged sedation at the pediatric intensive care unit.
    Flint RB; Brouwer CNM; Kränzlin ASC; Lie-A-Huen L; Bos AP; Mathôt RAA
    Paediatr Anaesth; 2017 Nov; 27(11):1098-1107. PubMed ID: 29030928
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Effect of Ketamine Infusion in the Treatment of Complex Regional Pain Syndrome: a Systemic Review and Meta-analysis.
    Zhao J; Wang Y; Wang D
    Curr Pain Headache Rep; 2018 Feb; 22(2):12. PubMed ID: 29404715
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of low-dose intranasal (S)-ketamine in patients with neuropathic pain.
    Huge V; Lauchart M; Magerl W; Schelling G; Beyer A; Thieme D; Azad SC
    Eur J Pain; 2010 Apr; 14(4):387-94. PubMed ID: 19733106
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Subanesthetic ketamine infusion therapy: a retrospective analysis of a novel therapeutic approach to complex regional pain syndrome.
    Correll GE; Maleki J; Gracely EJ; Muir JJ; Harbut RE
    Pain Med; 2004 Sep; 5(3):263-75. PubMed ID: 15367304
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ketamine and Norketamine: Enantioresolution and Enantioselective Aquatic Ecotoxicity Studies.
    Pérez-Pereira A; Ribeiro C; Teles F; Gonçalves R; M F Gonçalves V; Pereira JA; Carrola JS; Pires C; Tiritan ME
    Environ Toxicol Chem; 2022 Mar; 41(3):569-579. PubMed ID: 33289946
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Postoperative analgesia and sedation following pediatric cardiac surgery using a constant infusion of ketamine.
    Hartvig P; Larsson E; Joachimsson PO
    J Cardiothorac Vasc Anesth; 1993 Apr; 7(2):148-53. PubMed ID: 8477017
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stereoselective pharmacokinetics of ketamine and norketamine after racemic ketamine or S-ketamine administration in Shetland ponies sedated with xylazine.
    Larenza MP; Knobloch M; Landoni MF; Levionnois OL; Kronen PW; Theurillat R; Schatzmann U; Thormann W
    Vet J; 2008 Sep; 177(3):432-5. PubMed ID: 17604192
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacodynamic effects and pharmacokinetic profile of a long-term continuous rate infusion of racemic ketamine in healthy conscious horses.
    Lankveld DP; Driessen B; Soma LR; Moate PJ; Rudy J; Uboh CE; van Dijk P; Hellebrekers LJ
    J Vet Pharmacol Ther; 2006 Dec; 29(6):477-88. PubMed ID: 17083451
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Simultaneous infusions of propofol and ketamine in ponies premedicated with detomidine: a pharmacokinetic study.
    Nolan A; Reid J; Welsh E; Flaherty D; McCormack R; Monteiro AM
    Res Vet Sci; 1996 May; 60(3):262-6. PubMed ID: 8735519
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ketamine: A Review of Clinical Pharmacokinetics and Pharmacodynamics in Anesthesia and Pain Therapy.
    Peltoniemi MA; Hagelberg NM; Olkkola KT; Saari TI
    Clin Pharmacokinet; 2016 Sep; 55(9):1059-77. PubMed ID: 27028535
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of ketamine and three metabolites in Beagle dogs under sevoflurane vs. medetomidine comedication assessed by enantioselective capillary electrophoresis.
    Sandbaumhüter FA; Theurillat R; Bektas RN; Kutter APN; Bettschart-Wolfensberger R; Thormann W
    J Chromatogr A; 2016 Oct; 1467():436-444. PubMed ID: 27485149
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of the stereoselective biotransformation of ketamine to norketamine via determination of their enantiomers in equine plasma by capillary electrophoresis.
    Theurillat R; Knobloch M; Levionnois O; Larenza P; Mevissen M; Thormann W
    Electrophoresis; 2005 Oct; 26(20):3942-51. PubMed ID: 16167314
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The dose-dependent effect of S(+)-ketamine on cardiac output in healthy volunteers and complex regional pain syndrome type 1 chronic pain patients.
    Olofsen E; Sigtermans M; Noppers I; Niesters M; Mooren R; Bauer M; Aarts L; Sarton E; Dahan A
    Anesth Analg; 2012 Sep; 115(3):536-46. PubMed ID: 22575567
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CYP2B6*6 allele and age substantially reduce steady-state ketamine clearance in chronic pain patients: impact on adverse effects.
    Li Y; Jackson KA; Slon B; Hardy JR; Franco M; William L; Poon P; Coller JK; Hutchinson MR; Currow DC; Somogyi AA
    Br J Clin Pharmacol; 2015 Aug; 80(2):276-84. PubMed ID: 25702819
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estimation of the contribution of norketamine to ketamine-induced acute pain relief and neurocognitive impairment in healthy volunteers.
    Olofsen E; Noppers I; Niesters M; Kharasch E; Aarts L; Sarton E; Dahan A
    Anesthesiology; 2012 Aug; 117(2):353-64. PubMed ID: 22692377
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chiral Pharmacokinetics and Metabolite Profile of Prolonged-release Ketamine Tablets in Healthy Human Subjects.
    Hasan M; Modess C; Roustom T; Dokter A; Grube M; Link A; Rey H; Adler S; Meissner K; Siegmund W
    Anesthesiology; 2021 Aug; 135(2):326-339. PubMed ID: 34019627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.